A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
Status:
Completed
Trial end date:
2020-01-07
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the safety and tolerability of KBL697 in healthy
volunteers. KBL697 has been developed as a potential new treatment for atopic dermatitis
(AD).